Does RAVULIZUMAB-CWVZ Cause Product temperature excursion issue? 16 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Product temperature excursion issue have been filed in association with RAVULIZUMAB-CWVZ. This represents 0.2% of all adverse event reports for RAVULIZUMAB-CWVZ.
16
Reports of Product temperature excursion issue with RAVULIZUMAB-CWVZ
0.2%
of all RAVULIZUMAB-CWVZ reports
0
Deaths
0
Hospitalizations
How Dangerous Is Product temperature excursion issue From RAVULIZUMAB-CWVZ?
Of the 16 reports.
Is Product temperature excursion issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RAVULIZUMAB-CWVZ. However, 16 reports have been filed with the FAERS database.
What Other Side Effects Does RAVULIZUMAB-CWVZ Cause?
Fatigue (1,472)
Asthenia (727)
Headache (639)
Drug ineffective (570)
Off label use (451)
Muscular weakness (422)
Dyspnoea (414)
Malaise (353)
Haemoglobin decreased (346)
Myasthenia gravis (338)
What Other Drugs Cause Product temperature excursion issue?
SECUKINUMAB (219)
ADALIMUMAB (190)
ABATACEPT (158)
OFATUMUMAB (157)
INSULIN GLARGINE (130)
TOCILIZUMAB (129)
VEDOLIZUMAB (111)
ONABOTULINUMTOXINA (96)
BRENTUXIMAB VEDOTIN (94)
RISANKIZUMAB (88)
Which RAVULIZUMAB-CWVZ Alternatives Have Lower Product temperature excursion issue Risk?
RAVULIZUMAB-CWVZ vs REBAMIPIDE
RAVULIZUMAB-CWVZ vs REBETOL
RAVULIZUMAB-CWVZ vs REBIF
RAVULIZUMAB-CWVZ vs REBOXETINE
RAVULIZUMAB-CWVZ vs RECLAST